Jay Khambhati

HDL: Fact, fiction, or function? HDL cholesterol and cardiovascular risk

Marc Allard‐Ratick, Bryan Kindya, Jay Khambhati et al. · European Journal of Preventive Cardiology · 2019 · 67 citations

Metabolic Syndrome, Lipid Disorder, High-density Lipoprotein +15

Early clinical and sociodemographic experience with patients hospitalized with COVID-19 at a large American healthcare system

Cian P. McCarthy, Sean Murphy, Maeve Jones‐O’Connor et al. · EClinicalMedicine · 2020 · 53 citations · Full text

Reconfiguring Cardiac Rehabilitation to Achieve Panvascular Prevention: New Care Models for a New World

Pratik B. Sandesara, Devinder S. Dhindsa, Jay Khambhati et al. · Canadian Journal of Cardiology · 2018 · 19 citations · Full text

Heart Failure, Health Policy, Cardiovascular Disease +14

50Elevated HDL-C is associated with adverse cardiovascular outcomes

Marc Allard‐Ratick, Jay Khambhati, M. Topel et al. · European Heart Journal · 2018 · 14 citations · Full text

Comparison of the Association Between High-Sensitivity Troponin I and Adverse Cardiovascular Outcomes in Patients With Versus Without Chronic Kidney Disease

Pratik B. Sandesara, Wesley T. O’Neal, Ayman Samman Tahhan et al. · The American Journal of Cardiology · 2018 · 13 citations

Hypertension, Renal Function, Cardiovascular Disease +9